Levodopa-stimulated growth hormone secretion and diabetic retinopathy.


Journal Article

Since growth hormone has been implicated as a possible etiologic factor in the development of diabetic retinopathy, we examined growth hormone levels in two groups of growth-onset diabetics matched for age and duration of disease. The experimental group had definite proliferative diabetic retinopathy; the control group of growth-onset diabetics had no significant retinopathy. Basal and levodopa-stimulated levels of growth hormone were determined for each group. Growth hormone response could not be correlated with the presence or absence of diabetic retinopathy (P less than .05).

Full Text

Cited Authors

  • Holland, PM; Landers, MB; Lebovitz, HE; Wolbarsht, ML

Published Date

  • October 1, 1976

Published In

Volume / Issue

  • 82 / 4

Start / End Page

  • 612 - 618

PubMed ID

  • 970425

Pubmed Central ID

  • 970425

Electronic International Standard Serial Number (EISSN)

  • 1879-1891

International Standard Serial Number (ISSN)

  • 0002-9394

Digital Object Identifier (DOI)

  • 10.1016/0002-9394(76)90550-x


  • eng